Dandekar Atul bought MAZE
October 29, 2026 · Form 4 insider transaction
Dandekar Atul bought 6,643 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $69.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,643
Price
$10.42
Total value
$69.2K
InsiderDandekar Atul
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 29, 2026
Filing dateOctober 30, 2026
Shares owned after38,959
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.